SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,726.50 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 2,747.89 |
| Book Value / Share | 41.70 |
| Price / Book | n/a |
| NCAV ($M) | 2,198.30 |
| NCAV / Share | 33.36 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.06 |
| Return on Assets (ROA) | -0.04 |
| Return on Equity (ROE) | -0.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.86 |
| Current Ratio | 7.95 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3,472.35 |
| Assets | 4,021.95 |
| Liabilities | 1,274.05 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 275.65 |
| Operating Income | -188.34 |
| Net Income | 74.08 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -320.03 |
| Cash from Investing | 220.60 |
| Cash from Financing | -4.92 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| GDERF – Galderma Group AG | GFOO – Genufood Energy Enzymes Corp. |
| GIFLF – Grifols, S.A. | GLUC – Glucose Health, Inc. |
| GNCAQ – Genocea Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io